AmpliPhi Biosciences intends to develop the commercial potential of its products through licensing partners on a global basis. AmpliPhi will develop its lead products through initial clinical development and then seek global and/or regional partners.
In the meantime, AmpliPhi welcomes approaches from interested partners, as well as companies wishing to co-develop AmpliPhi’s technology in other ways.
April 17th 2013
AmpliPhi Establishes Collaboration with IntrexonMore
February 04th 2013
AmpliPhi Receives Notice of Allowance on Key Patent for its Bacteriophage TherapyMore
November 13th 2012
AmpliPhi and Special Phage Services Complete MergerMore
October 19th 2012
Ampliphi Presents Encouraging Pre-Clinical Data on Phage Therapies to Treat Bacterial Lung InfectionMore
October 12th 2012
AmpliPhi CSO Dr. David Harper presents at NACFC 2012More